Crossmark

Healthcare use by 30,000 patients with irritable bowel syndrome (IBS) in France: a 5-year retrospective and one-year prospective national observational study

Crossref DOI link: https://doi.org/10.1186/s12876-019-1031-z

Published Online: 2019-06-27

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sabaté, Jean-Marc

Rivière, Sébastien

Jouet, Pauline

Gastaldi-Menager, Christelle

Fagot-Campagna, Anne

Tuppin, Philippe https://orcid.org/0000-0001-5698-9215
License Information

Text and Data Mining valid from 2019-06-27

Version of Record valid from 2019-06-27
More Information

Article History

Received: 30 October 2018

Accepted: 21 June 2019

First Online: 27 June 2019

Ethics approval and consent to participate

: This study was based on an administrative database (Snds) used for reimbursement. Analyses of Snds data by Cnam were performed with the permission of the CNIL (French data protection authority) and by decree.

: Not applicable.

: The authors declare that they have no competing interest.

Document is current

Any future updates will be listed below